Search Results
Test Catalog
FMBNY - Overview: Fetomaternal Bleed, New York, Blood
Determining the volume of fetal-to-maternal hemorrhage for the purposes of recommending an increased dose of the Rh immune globulin This test is used only for specimens collected in New York state.
FMB - Overview: Fetomaternal Bleed, Flow Cytometry, Blood
Determining the volume of fetal-to-maternal hemorrhage for the purposes of recommending an increased dose of the Rh immune globulin
TREE3 - Overview: Tree Panel #3, Serum
Establishing a diagnosis of an allergy to tress in panel #3 Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm...
PAS8 - Overview: Pediatric Allergy Screen >8 Years, Serum
Establishing a diagnosis of an allergy to house dust mites, short ragweed, timothy grass, cat epithelium, or Alternaria tenuis Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for...
SEAFP - Overview: Seafood Allergen Profile, Serum
Establishing a diagnosis of an allergy to seafood (cod, crab, lobster, shrimp, or tuna) Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response or anaphylactic...
GUS - Overview: Guselkumab, Serum
Assessing the response to guselkumab therapy Assessing the need for dose escalation Evaluating the potential for dose de-escalation or discontinuation of therapy Monitoring patients who need to be above a certain guselkumab...
BAP - Overview: Bone Alkaline Phosphatase, Serum
Diagnosis and assessment of severity of metabolic bone disease including Paget disease, osteomalacia, and other states of high bone turnover Monitoring efficacy of antiresorptive therapies including postmenopausal osteoporosis treatment...
NEREG - Overview: Northeast Regional Allergen Profile, Serum
Establishing a diagnosis of an allergy to a Northeast regional allergen Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response or anaphylactic episode -To confirm...
AAMSD - Overview: Amino Acids, Maple Syrup Urine Disease Panel, Plasma
Follow-up of patients with maple syrup urine disease Monitoring of dietary compliance for patients with maple syrup urine disease
BRIVA - Overview: Brivaracetam, Plasma
Assessing compliance and toxicity for brivaracetam
POSA - Overview: Posaconazole, Serum
Monitoring posaconazole therapy
CITR2 - Overview: Citrate Concentration, Random, Urine
Diagnosing risk factors for patients with calcium kidney stones Monitoring results of therapy in patients with calcium stones or renal tubular acidosis
DULOX - Overview: Duloxetine, Serum
Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance
CCTR - Overview: Calcium/Creatinine Ratio, Random, Urine
Calculation of calcium concentration per creatinine concentration
MTXSG - Overview: Methotrexate Post Glucarpidase, Serum
Monitoring methotrexate concentrations post-glucarpidase therapy Documenting failure to respond that may be due to noncompliance Guiding dosage adjustments in patients with kidney failure
PENTS - Overview: Pentobarbital, Serum
Monitoring of pentobarbital therapy treatment
VITB2 - Overview: Riboflavin (Vitamin B2), Plasma
Evaluation of individuals who present the signs of ariboflavinosis
MPHNU - Overview: Methylphenidate and Metabolite, Random, Urine
Monitoring urine methylphenidate and ritalinic acid concentrations to assess compliance in patients
FALBU - Overview: Albuterol, Serum/Plasma
Albuterol, Serum/Plasma
5AINH - Overview: Factor V Inhibitor Profile, Professional Interpretation
Interpretation of testing for factor V inhibitors
8AINH - Overview: Factor VIII Inhibitor Profile, Professional Interpretation
Interpretation for the detection of the presence and titer of a specific factor inhibitor directed against coagulation factor VIII
FFES - Overview: Estradiol Free, Serum (includes Estradiol and SHBG)
Estradiol Free, Serum (includes Estradiol and SHBG)
FHAL - Overview: Triazolam (Halcion)
Triazolam (Halcion)
Venison IgE
17PRN - Overview: Pregnenolone and 17-Hydroxypregnenolone, Serum
An ancillary test for congenital adrenal hyperplasia (CAH), particularly in situations in which a diagnosis of both 21- and 11-hydroxylase deficiency have been ruled out Confirming a diagnosis of 3-beta-hydroxysteroid dehydrogenase...
PBDV - Overview: Lead, Venous, with Demographics, Blood
Detecting lead toxicity in venous blood specimens
MYODT - Overview: MYOD1 Mutation Analysis, Next-Generation Sequencing, Tumor
Identifying specific mutations within the MYOD1 gene to assist in tumor diagnosis/classification Assisting in the clinical management of patients with spindle cell and sclerosing rhabdomyosarcoma
Aiding in the distinction between the myeloproliferative neoplasm polycythemia vera and other secondary erythrocytosis
GALMP - Overview: Galactosemia, GALT Gene, Variant Panel, Varies
Second-tier test for confirming a diagnosis of galactosemia as indicated by enzymatic testing or newborn screening Carrier testing family members of an affected individual of known genotype (has variants included in the panel) Resolution...
MCMRU - Overview: Mast Cell Mediators, Random, Urine
Evaluating patients at risk for mast cell activation syndrome (eg, systemic mastocytosis) using random urine collections
TRCHG - Overview: ToRCH Profile IgG, Serum
Determining immune status of individuals to the rubella virus following vaccination or prior exposure Indicating past or recent infection with Toxoplasma gondii, cytomegalovirus, or herpes simplex virus (HSV) Distinguishing between...
Screening for cervical carcinoma or intraepithelial lesions and the presence or absence of high-risk human papillomavirus (HR-HPV) when screening women aged 30 to 65 years for possible cervical neoplasia Aiding in triaging women with...
Screening for common variable immunodeficiency and hyper-IgM syndromes Assessing B-cell subset reconstitution after stem cell or bone marrow transplant Assessing response to B-cell-depleting immunotherapy This test is not indicated...
BNZX - Overview: Benzodiazepines Confirmation, Chain of Custody, Random, Urine
Detecting drug use involving benzodiazepines such as alprazolam, chlordiazepoxide, clonazepam, diazepam, midazolam, oxazepam, temazepam, clobazam, flunitrazepam, flurazepam, lorazepam, prazepam, triazolam, and zolpidem, in urine specimens...
BUAUC - Overview: Busulfan, Intravenous Dose, Area Under the Curve, Plasma
Guiding dosage adjustments to achieve complete bone marrow ablation while minimizing dose-dependent toxicity
HSMWB - Overview: Hepatosplenomegaly Panel, Blood
As a component of the initial evaluation of a patient presenting with hepatosplenomegaly This test is not useful for the identification of carriers. This test should not be used as a monitoring for patients with confirmed diagnoses.
IGA - Overview: Immunoglobulin A (IgA), Serum
Detection or monitoring of IgA monoclonal gammopathies and IgA-related immune deficiencies
CHIKV - Overview: Chikungunya IgM and IgG, Antibody, Serum
Aiding in the diagnosis of recent infection with Chikungunya virus in patients with recent travel to endemic areas and a compatible clinical syndrome
Confirming the diagnosis of dermatofibrosarcoma protuberans (DFSP)/giant cell fibroblastoma (GCF) and excluding other spindle neoplasms that closely simulate the DFSP histology, including dermatofibroma (benign fibrous histiocytoma),...
CALR - Overview: CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN), Varies
Rapid and sensitive detection of insertion and deletion-type mutations in exon 9 of CALR Aiding in distinguishing between reactive thrombocytosis and leukocytosis versus a myeloproliferative neoplasm (MPN), especially essential...
TOPSU - Overview: Targeted Opioid Screen, Random, Urine
Qualitatively (present vs not detected) identifying 33 opioid compounds (parent drug and metabolites) in urine to help determine compliance or identify illicit opioid drug use This test is not intended for use in employment-related...
VZVPV - Overview: Varicella-Zoster Virus, Molecular Detection, PCR, Varies
Rapid (qualitative) detection of varicella-zoster virus DNA in clinical specimens for laboratory diagnosis of disease due to this virus This test should not be used to screen asymptomatic patients.
TOSU - Overview: Targeted Opioid Screen, Random, Urine
Determining compliance or identifying illicit opioid drug use using urine specimens This test is not intended for employment-related testing.
BMAMA - Overview: Basic Metabolic Panel, Serum
Routine health monitoring or patient monitoring while hospitalized for information regarding metabolism, including the current kidney status, electrolyte, and acid/base balance, and blood glucose
PCDGG - Overview: Primary Ciliary Dyskinesia Gene Panel, Varies
Providing a genetic evaluation for patients with a personal or family history suggestive of primary ciliary dyskinesia Establishing a diagnosis of primary ciliary dyskinesia
TTBS - Overview: Testosterone, Total and Bioavailable, Serum
Recommended second-level test for suspected increases or decreases in physiologically active testosterone: -Assessment of androgen status in cases with suspected or known sex hormone-binding globulin binding abnormalities -Assessment of...
STHPV - Overview: ThinPrep Screen with Human Papillomavirus (HPV) Reflex, Varies
Managing and triaging of patients, aged 21 years or older, with abnormal Pap results Screening for detection of high-risk (HR) human papillomavirus (HPV) genotypes associated with the development of cervical cancer Aids in triaging...
ALKP - Overview: Alkaline Phosphatase, Total and Isoenzymes, Serum
Aid in the diagnosis and treatment of liver, bone, intestinal, and parathyroid diseases Determining the tissue source of increased alkaline phosphatase (ALP) activity in serum Differentiating between liver and bone sources of elevated ALP
AN3TC - Overview: Antineuronal Nuclear Antibody Type 3 (ANNA-3) Titer, Spinal Fluid
Evaluating patients who present with a subacute neurological disorder of undetermined etiology and have risk factors for primary lung carcinoma Reporting an end titer result from cerebrospinal fluid specimens
AN3TS - Overview: Antineuronal Nuclear Antibody Type 3 (ANNA-3) Titer, Serum
Evaluating patients who present with a subacute neurological disorder of undetermined etiology and have risk factors for primary lung carcinoma Reporting an end titer result from serum specimens
Site Search
Hot Topic Archives - Page 5 of 5 - Insights
Skip to Content MayoACCESS MayoLINK...
Perspectives Archives - Page 5 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Archives - Page 5 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
People Archives - Page 5 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Industry Archives - Page 5 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...